参考文献/References:
[1] LIU Xiaoguang, NIE Litong, ZHANG Yilei, et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis[J]. Nature Cell Biology, 2023, 25 (3): 404-414.
[2] ZHOU Jiankang, FAN Xin, CHENG Jian, et al. PDLIM1: structure, function and implication in cancer[J]. Cell Stress, 2021, 5 (8): 119-127.
[3] TSUNODA S, SIERRALTA J, SUN Y, et al. A multivalent PDZ-domain protein assembles signalling complexes in a G-protein-coupled cascade[J]. Nature, 1997, 388 (6639): 243-249.
[4] QIU Cuipeng, DUAN Yaru, WANG Bofei, et al. Serum anti-PDLIM1 autoantibody as diagnostic marker in ovarian cancer[J]. Frontiers in Immunology, 2021,12: 698312.
[5] HUANG Zhao, ZHOU Jiankang, WANG Kui, et al. PDLIM1 inhibits tumor metastasis through activating hippo signaling in hepatocellular carcinoma[J].Hepatology, 2020, 71 (5): 1643-1659.
[6] TAN Yeru, LI Yuehua, ZHU Hongbo, et al. MiR-187/PDLIM1 gets involved in gastric cancer progression and cisplatin sensitivity of cisplatin by mediating the Hippo-YAP signaling pathway[J]. Journal of Oncology, 2022, 2022: 5456016.
[7] 张涛元, 丁雪梅, 李俏，等. 人非小细胞肺癌组织中转录因子E2F 家族表达与临床病理特征及预后的相关性分析[J]. 现代检验医学杂志, 2022, 37(4): 87-91. ZHANG Taoyuan, DING Xuemei, LI Qiao, et al. Correlation analysis of transcription factor E2F family expression with clinicopathological features and prognosis in human non-small cell lung cancer[J].Journal of Modern Laboratory Medicine, 2022, 37(4): 87-91.
[8] SUNG H, FERLAY J, SIEGEL R L, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer Journal for Clinicians, 2021, 71 (3): 209-249.
[9] 吴良银, 李文丽, 刘俊. 基于GEO 数据的病毒相关性肝癌潜在生物基因标志物的筛选及生物信息学分析[J]. 现代检验医学杂志, 2021, 36(6): 106-110. WU Liangyin, LI Wenli, LIU Jun. Screening and bioinformatics analysis of potential biomarkers for virus-associated hepatocellular carcinoma based on GEO data [J]. Journal of Modern Laboratory Medicine, 2021, 36(6):106-110.
[10] GROSSBERG A J, CHU L C, DEIG C R, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma[J]. CA: A Cancer Journal for Clinicians, 2020, 70 (5): 375-403.
[11] XU Chunxiao, ZANG Yusheng, ZHAO Yuxiang, et al. Comprehensive pan-cancer analysis confirmed that ATG5 promoted the maintenance of tumor metabolism and the occurrence of tumor immune escape[J].Frontiers in Oncology, 2021, 11:652211.
[12] LIU Zikai, CHEN Yiqun, SHEN Tong. Evidence based on an integrative analysis of multi-omics data on METTL7A as a molecular marker in pan-cancer[J].Biomolecules, 2023, 13 (2): 195.
[13] YI Wanwan, QIAO Tingting, YANG Ziyu, et al. The regulation role and diagnostic value of fibrinogen-like protein 1 revealed by pan-cancer analysis[J]. Materials Today Bio, 2022, 17: 100470.
[14] ZHENG Peijie, ZHOU Chuntao, DING Yuemin, et al. Disulfidptosis: a new target for metabolic cancer therapy[J]. Journal of Experimental & Clinical Cancer Research, 2023,42 (1):103.
[15] ONG Meishan, DENG Shuo, HALIM C E, et al. Cytoskeletal proteins in cancer and intracellular stress: a therapeutic perspective[J]. Cancers(Basel), 2020, 12 (1): 238.
[16] LI L M, LUO F J, SONG X. MicroRNA-370-3p inhibits cell proliferation and induces chronic myelogenous leukaemia cell apoptosis by suppressing PDLIM1/Wnt/β-catenin signaling[J]. Neoplasma. 2020, 67 (3): 509-518.
[17] 陆林发，王海生. 细胞骨架蛋白PDLIM1 在肿瘤中的研究进展[J]. 生命的化学, 2018, 38(6): 827-831. LU Linfa, WANG Haisheng. Research progress of PDLIM1 in tumors[J]. Chemistry of Life, 2018,38(6): 827-831.
[18] 刘永昌, 郝志强, 赵玉成, 等. 肝细胞肝癌组织中TFAM，PDLIM1 表达及与患者临床病理特征和预后的关系[J]. 山东医药, 2023, 63(10): 6-10. LIU Yongchang, HAO Zhiqiang, ZHAO Yucheng, et al. Expression of TFAM and PDLIM1 in hepatocelluar carcinoma and their relationships with clinicopathological characteristics and prognosis[J]. Shandong Medical Journal, 2023, 63(10): 6-10.
[19] FU Chunmei, JIANG Aimin. Dendritic cells and CD8 T cell immunity in tumor microenvironment[J]. Frontiers in Immunology, 2018, 9: 3059.
[20] YE Wenrui, LUO Cong, LIU Fangkun, et al. CD96 correlates with immune infiltration and impacts patient prognosis: a pan-cancer analysis[J]. Frontiers in Oncology. 2021, 11: 634617.
[21] YAN Li, SONG Xiaole, YANG Gang, et al. Identification and validation of immune infiltration phenotypes in laryngeal squamous cell carcinoma by integrative multi-omics analysis[J]. Frontiers in Immunology. 2022, 13, 843467.
[22] 龚富强. PDLIM1 在乳腺癌组织中的表达与预后的关系[D]. 衡阳：南华大学,2021: 000356. GONG Fuqiang. Correlations of PDLIM1 Expression to Prognosis of Breast Cancer[D]. Hengyang: University of South China, 2021: 000356.
[23] LI Huafu, WANG Chunming, LAN Linxiang, et al. High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelialmesenchymal transition in gastric cancer[J]. Aging. 2021, 13 (4): 5197-5225.
[24] LIU Jiaqiang, ZHAO Xintong, QIN Feiyun, et al. Isoliquiritigenin mitigates oxidative damage after subarachnoid hemorrhage in vivo and in vitro by regulating Nrf2-dependent signaling pathway via targeting of SIRT1[J]. Phytomedicine. 2022, 105: 154262.
[25] HUANG Xiaozhong, SHI Yujuan, CHEN Hongjin, et al. Isoliquiritigenin prevents hyperglycemia-induced renal injuries by inhibiting inflammation and oxidative stress via SIRT1-dependent mechanism[J]. Cell Death & Disease. 2020, 11 (12): 1040.
[26] AL-QAHTANI W H, ALSHAMMARI G M, AJAREM JS, et al. Isoliquiritigenin prevents Doxorubicininduced hepatic damage in rats by upregulating and activating SIRT1[J]. Biomedicine & Pharmacotherapy, 2022,146:112594.
[27] ZHANG Zhu, CHEN Wenqing, ZHANG Shiqing, et al. Isoliquiritigenin inhibits pancreatic cancer progression through blockade of p38 MAPK-regulated autophagy[J]. Phytomedicine. 2022, 106: 154406.
[28] CHEN H Y, CHIANG Y F, HUANG J S, et al. Isoliquiritigenin reverses epithelial-mesenchymal transition through modulation of the TGF-β/Smad signaling pathway in endometrial cancer[J]. Cancers. 2021, 13 (6):1236.
[29] WANG Gang, YU Yang, WANG Yuzhu, et al. The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer[J]. Artificial Cells, Nanomedicine, and Biotechnology. 2020, 48 (1): 1231-1249.
相似文献/References:
[1]陈龙梅,杨振华.基于GEO数据库对类风湿性关节炎相关基因筛选及生物信息学分析[J].现代检验医学杂志,2021,36(02):49.[doi:doi:10.3969/j.issn.1671-7414.2021.02.012]
CHEN Long-mei,YANG Zhen-hua.Gene Screening and Bioinformatics Analysis of Rheumatoid Arthritis Based on GEO Database[J].Journal of Modern Laboratory Medicine,2021,36(01):49.[doi:doi:10.3969/j.issn.1671-7414.2021.02.012]
[2]吴良银a,李文丽b,刘 俊b.基于GEO数据的病毒相关性肝癌潜在生物基因标志物的筛选及生物信息学分析[J].现代检验医学杂志,2021,36(06):106.[doi:10.3969/j.issn.1671-7414.2021.06.022]
WU Liang-yin,LI Wen-li,LIU Jun.Screening and Bioinformatics Analysis of Potential Biomarkers for Virus-associated Hepatocellular Carcinoma Based on GEO Data[J].Journal of Modern Laboratory Medicine,2021,36(01):106.[doi:10.3969/j.issn.1671-7414.2021.06.022]
[3]张涛元,丁雪梅,李 俏,等.人非小细胞肺癌组织中转录因子E2F 家族表达与临床病理特征及预后的相关性分析[J].现代检验医学杂志,2022,37(04):87.[doi:10.3969/j.issn.1671-7414.2022.04.017]
ZHANG Tao-yuan,DING Xue-mei,LI Qiao,et al.Correlation Analysis of Transcription Factor E2F Family Expression with Clinicopathological Features and Prognosis in Human Non-small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2022,37(01):87.[doi:10.3969/j.issn.1671-7414.2022.04.017]
[4]侯芳霞,刘 琳,张 维,等.基于GEO 数据库筛选稳定性心绞痛患者外周血关键差异基因及诊断模型构建[J].现代检验医学杂志,2022,37(06):19.[doi:10.3969/j.issn.1671-7414.2022.06.004]
HOU Fang-xia,LIU Lin,ZHANG Wei,et al.Identification of Hub Genes and Differential Expression Genes for Peripheral Blood Samples of Stable Angina Pectoris Based on GEO Databases[J].Journal of Modern Laboratory Medicine,2022,37(01):19.[doi:10.3969/j.issn.1671-7414.2022.06.004]
[5]毛 俊,沈秀芬,马 润,等.基于TCGA 和GEO 数据库建立了肝内胆管癌的预后风险模型及验证分析[J].现代检验医学杂志,2023,38(03):40.[doi:10.3969/j.issn.1671-7414.2023.03.008]
MAO Jun,SHEN Xiu-fen,MA Run,et al.Establishment and Verification of Prognostic Risk Model of Intrahepatic Cholangiocarcinoma Based on TCGA and GEO Database[J].Journal of Modern Laboratory Medicine,2023,38(01):40.[doi:10.3969/j.issn.1671-7414.2023.03.008]
[6]侯 丽,张 丽,唐 婧,等.基于GEO 对多发性骨髓瘤关键基因生物信息学分析及免疫浸润模式与验证[J].现代检验医学杂志,2023,38(05):23.[doi:10.3969/j.issn.1671-7414.2023.05.005]
HOU Li,ZHANG Li,TANG Jing,et al.Bioinformatics Analysis and Verify Core Genes and Immune Infiltration Patterns in Multiple Myeloma Based on GEO[J].Journal of Modern Laboratory Medicine,2023,38(01):23.[doi:10.3969/j.issn.1671-7414.2023.05.005]
[7]曹 君,金婕妤,张 胜,等.生物信息学方法筛选IL-3和IL-3+SCF诱导的小鼠骨髓来源肥大细胞的差异表达基因及相关信号通路分析[J].现代检验医学杂志,2024,39(01):16.[doi:10.3969/j.issn.1671-7414.2024.01.004]
CAO Jun,JIN Jieyu,ZHANG Sheng,et al.Screening of IL-3 and IL-3+SCF Induce Differentially Expressed Genes and Signaling Pathways in Bone Marrow-derived Mast Cells Based on Bioinformatics[J].Journal of Modern Laboratory Medicine,2024,39(01):16.[doi:10.3969/j.issn.1671-7414.2024.01.004]
[8]钟双泽,陈尚金,林汉胜,等.基于TCGA 数据库生物信息学分析构建肾癌N6- 甲基腺苷相关LncRNA 配对模型及其预后预测价值研究[J].现代检验医学杂志,2024,39(02):68.[doi:10.3969/j.issn.1671-7414.2024.02.013]
ZHONG Shuangze,CHEN Shangjin,LIN Hansheng,et al.Construction of N6-methyladenosine Related LncRNA Pairing Model for Renal Cell Carcinoma Based on Bioinformatics Analysis of TCGA Database and Its Prognostic Value Research[J].Journal of Modern Laboratory Medicine,2024,39(01):68.[doi:10.3969/j.issn.1671-7414.2024.02.013]